DRIEHAUS CAPITAL MANAGEMENT INC 13D and 13G filings for Crinetics Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 07:54 am Sale |
2023-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
DRIEHAUS CAPITAL MANAGEMENT INC | 5,039,477 7.540% |
-585,267 (-10.41%) |
Filing |
| 2023-02-08 11:32 am Purchase |
2022-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
DRIEHAUS CAPITAL MANAGEMENT INC | 5,624,744 10.450% |
831,106 (+17.34%) |
Filing |
| 2022-01-10 11:09 am Purchase |
2021-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
DRIEHAUS CAPITAL MANAGEMENT INC | 4,793,638 10.090% |
4,793,638 (New Position) |
Filing |